Where Money Talks & Markets Listen
Dark
Light

JPMorgan Doubles Down on Tesla Warning

April 6, 2026
jpmorgan-doubles-down-on-tesla-warning

JPMorgan is urging investors to be far more skeptical about Tesla’s valuation, arguing that the stock market is pricing in a future turnaround so large and so distant that it may be difficult to justify against the company’s current operating performance. The warning comes at a time when Tesla shares, despite falling 20% this year, are still being supported by expectations that its long term ambitions in robotaxis and humanoid robotics will eventually outweigh near term weakness in its core car business.

The bank’s concern is not simply that Tesla is under pressure today. It is that the market appears willing to look well beyond weakening vehicle fundamentals and assume a dramatic improvement later in the decade. JPMorgan analyst Ryan Brinkman argues that this creates a risky imbalance between present performance and future hope, especially when investors are being asked to place so much value on businesses that are not yet proven at scale.

That makes Tesla’s current investment case unusually dependent on belief rather than evidence. For supporters, the company remains an autonomous driving and robotics story in the making. For critics such as JPMorgan, that story is demanding too much patience while the financial base that must fund it is getting weaker.

JPMorgan says the market is pricing in too much future success

Brinkman reiterated a Sell rating on Tesla and set a $145 price target, implying a potential drop of about 60% from current levels. While that target stands well below the broader Wall Street average of $360, it reflects his broader argument that the stock is still being valued as if a major positive inflection is justifiable, even though expectations for the company’s financial and operating performance through the end of the decade have deteriorated.

His core point is that Tesla shares and analyst price targets have risen sharply even as outlooks for the business have weakened across multiple metrics and time frames. In that reading, the market is effectively betting that Tesla will deliver materially better performance sometime beyond the end of this decade, a bet that requires investors to overlook both execution risk and the cost of waiting so long for results to materialize.

That critique goes directly to the heart of Tesla’s valuation debate. The issue is no longer whether the company is innovative. It is whether innovation alone is enough to support a stock price that still assumes a much stronger future than the current business seems to be delivering.

Vehicle results continue to disappoint

The latest delivery data has done little to ease those concerns. Tesla delivered 358,023 vehicles in the first quarter, missing analyst expectations that ranged from roughly 366,000 to 370,000 units. Although that figure represented a 6.3% increase from a year earlier, it came against a weak base and still showed a sharp sequential decline from the company’s record fourth quarter.

Those numbers matter because vehicle sales remain the core of Tesla’s revenue engine. However ambitious its technology plans may be, the company still depends overwhelmingly on its automotive business to generate cash and justify scale. If that business is stalling, then the gap between current fundamentals and future aspirations becomes harder to ignore.

Tesla’s position is especially sensitive because the company has already posted annual delivery declines in the past two years. That weakens the argument that temporary softness can be dismissed as a short term fluctuation. Instead, it suggests a broader struggle to maintain growth in a more mature and competitive electric vehicle market.

Demand and competition are creating real pressure

The headwinds facing Tesla are piling up. The expiration of the $7,500 U.S. federal tax credit for electric vehicles at the end of last year removed an important support for domestic demand. At the same time, high interest rates have made car financing more expensive, placing additional pressure on affordability for potential buyers.

Beyond macroeconomic pressure, Tesla is also dealing with intensifying competition. Chinese manufacturers such as BYD continue to expand aggressively, while traditional automakers including Mercedes-Benz, General Motors and Ford remain committed to electric vehicles even if they are pacing their investments more carefully than before. That competitive environment makes it much harder for Tesla to rely on brand strength alone to hold pricing power or preserve growth.

JPMorgan’s warning reflects the idea that these challenges are not minor obstacles. They are structural issues affecting demand, margins, and market positioning at the same time. That makes any assumed rebound later in the decade more difficult to treat as a simple inevitability.

Musk’s future bets are carrying more of the story

To keep investor enthusiasm intact, Elon Musk is pointing toward 2026 as a pivotal year for Tesla’s next generation of products. The company’s dedicated robotaxi, or Cybercab, is expected to begin initial production this month and is meant to anchor a future autonomous ridesharing network. Musk is also accelerating development of the Optimus humanoid robot, with the aim of using it in Tesla factories for repetitive work before year end.

Those projects are central to why many investors remain willing to give Tesla the benefit of the doubt. If they succeed, the company could evolve beyond being primarily an electric car manufacturer and move into entirely new categories with much larger long term profit potential. That is the promise behind the valuation premium.

But JPMorgan’s caution is that promise alone does not eliminate risk. Expansion into higher volume, lower priced segments, while also trying to lead in autonomy and robotics, demands flawless execution in areas where demand, competition, and commercialization remain uncertain. Tesla may still produce a breakthrough beyond the car business. The problem for investors is that the stock already appears to assume something very close to that outcome. JPMorgan’s view is that the optimism built into the valuation remains too large for a company whose present performance continues to move in the opposite direction.